Cited by 70Nutrition and Health in AgingHormonal and reproductive studiesProstate Cancer Treatment and Research

Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy

Open access
Storer, Thomas W, Miciek, Renee, Travison, Thomas G·2012·Asian Journal of Andrology

Abstract

Prostate cancer (PCa) is the most common visceral malignancy in men with androgen deprivation therapy (ADT) the preferred therapy to suppress testosterone production and hence tumor growth. Despite its effectiveness in lowering testosterone, ADT is associated with side effects including loss of muscle mass, diminished muscle strength, decrements in physical performance, earlier fatigue and declining quality of life. This review reports a survey of the literature with a focus on changes in muscle strength, physical function and body composition, due to short-term and long-term ADT. Studies in these areas are sparse, especially well-controlled, prospective randomized trials. Cross-sectional and longitudinal data (up to 2 years) for men with PCa treated with ADT as well as patients with PCa not receiving ADT and age-matched healthy men are presented when available. Based on limited longitudinal data, the adverse effects of ADT on muscle function, physical performance and body composition occur shortly after the onset of ADT and tend to persist and worsen over time. Exercise training is a safe and effective intervention for mitigating these changes and initial guidelines for exercise program design for men with PCa have been published by the American College of Sports Medicine. Disparities in study duration, types of studies and other patient-specific variables such as time since diagnosis, cancer stage and comorbidities may all affect an understanding of the influence of ADT on health, physical performance and mortality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/aja.2011.104

Cites

136 of 136 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Longitudinal studies of muscle loss, strength, and performance following castration for prostate cancer show progressive loss for 24 months.

    “Comparable longitudinal studies of muscle loss, strength, and performance following castration for prostate cancer are well summarized (185), showing progressive loss for 24 months (see Fig. 4).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 137 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Gayda M, Temfemo A, Choquet D, Ahmaidi S. Cardiorespiratory requirements and reproducibility of the six-minute walk test in elderly patients with coronary artery disease. Arch Phys Med Rehabil 2004; 85: 1538-43.

Cited by

Sorted by citations

Authors
Storer, T. W., Miciek, R., & Travison, T. G.
Affiliations
Boston University (US)
Venue
Asian Journal of Andrology
Publisher
Medknow
Published
2012-02-27
Volume
14
Issue
2
Pages
204-221
ISSN
  • 1008-682X (ISSN-L)
  • 1745-7262
OpenAlex
W1964651662
Cited by
70
References
137
Citations by year
2026: 3 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 9 · 2020: 4 · 2019: 5 · 2018: 4 · 2017: 8 · 2016: 5 · 2015: 5 · 2014: 4 · 2013: 5 · 2012: 2
FWCI
0.55
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • Asian Journal of Andrology (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
Keywords
prostate cancer, androgen deprivation therapy, muscle strength, muscle mass, physical performance, body composition, exercise training, testosterone suppression, fatigue, quality of life, cancer treatment side effects
MeSH terms
Androgen Antagonists, Body Composition, Fatigue, Humans, Male, Motor Activity, Prostatic Neoplasms, Risk Factors, Muscle, Skeletal, Muscle Weakness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review